Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
1,853,785
-
Shares change
-
+95,307
-
Total reported value, excl. options
-
$248,652,790
-
Value change
-
+$13,013,731
-
Put/Call ratio
-
31%
-
Number of buys
-
26
-
Number of sells
-
-31
-
Price
-
$134.12
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2017
91 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q3 2017.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,853,785 shares
.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (1,029,394 shares), UBS Group AG (182,142 shares), MORGAN STANLEY (86,793 shares), ROYAL BANK OF CANADA (60,004 shares), MURPHY CAPITAL MANAGEMENT INC (48,071 shares), Endurant Capital Management LP (38,799 shares), Strategic Financial Services, Inc, (27,172 shares), BOSTON RESEARCH & MANAGEMENT INC (21,988 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (20,823 shares), and RAYMOND JAMES & ASSOCIATES (18,810 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.